Revenue and Profit - Revenue for Q3 2022 reached ¥628,920,239.19, an increase of 17.21% year-over-year, while year-to-date revenue was ¥2,028,858,436.64, up 22.36% compared to the same period last year[4] - Net profit attributable to shareholders was ¥1,334,719.69, a decrease of 74.46% year-over-year, with year-to-date net profit at ¥44,249,710.35, an increase of 14.19%[4] - Basic earnings per share for Q3 2022 were ¥0.0012, down 76.92% year-over-year, while diluted earnings per share were also ¥0.0012, showing the same decline[4] - Net profit for the current period was ¥47,172,900.31, compared to ¥43,336,196.24 in the previous period, reflecting an increase of approximately 6.3%[26] - The net profit attributable to the parent company shareholders for Q3 2022 was ¥44,249,710.35, an increase from ¥38,749,901.96 in the same period last year, representing a growth of approximately 3.86%[27] - The total comprehensive income for Q3 2022 was ¥46,634,781.79, compared to ¥51,229,088.00 in Q3 2021, indicating a decrease of about 8.91%[27] Cash Flow and Assets - The net cash flow from operating activities for the year-to-date period was ¥304,272,487.38, reflecting a significant increase of 231.36%[4] - The net cash flow from operating activities for the period was ¥304,272,487.38, significantly up from ¥91,825,044.89 in the previous year, marking an increase of approximately 231.36%[29] - Cash and cash equivalents at the end of Q3 2022 stood at ¥551,080,662.03, down from ¥640,302,877.54 at the beginning of the period, reflecting a decrease of about 13.88%[30] - The total cash inflow from operating activities was ¥2,108,576,095.54, compared to ¥1,692,950,522.51 in the same period last year, showing an increase of approximately 24.48%[29] - The company experienced a 99.39% decrease in cash inflow from investment activities, reflecting a reduction of ¥30,846.33 million compared to the previous year[12] - The net increase in cash and cash equivalents decreased by 441.51% compared to the same period last year, with an absolute decrease of 115.35 million RMB, primarily due to the net cash flow from operating activities being less than the decrease in cash flow from investing and financing activities[14] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,867,581,511.42, a decrease of 4.96% from the end of the previous year[4] - The total assets decreased to ¥3,867,581,511.42 from ¥4,069,421,166.85, a decline of about 5%[23] - Total liabilities decreased to ¥2,033,000,441.55 from ¥2,232,686,402.91, showing a reduction of approximately 8.9%[23] - Current assets totaled ¥1,994,776,202.20, down from ¥2,183,321,715.52, indicating a decrease of about 8.6%[22] - Cash and cash equivalents were reported at ¥623,984,340.39, a decrease from ¥676,870,643.54, reflecting a decline of approximately 7.8%[22] - Accounts receivable decreased to ¥696,286,897.17 from ¥741,811,792.81, a reduction of about 6.1%[22] - Inventory levels dropped to ¥365,008,925.70 from ¥505,645,822.70, indicating a significant decrease of approximately 28%[22] - The company reported a decrease in long-term borrowings to ¥23,997,035.01 from ¥65,097,319.44, a decline of about 63.2%[23] Operating Costs and Expenses - The company reported a 50.18% increase in operating costs year-over-year, amounting to an absolute increase of ¥39,387.37 million, primarily due to higher revenue[10] - Total operating costs amounted to ¥1,952,142,934.10, up from ¥1,567,103,646.91, indicating a rise of about 24.5%[26] - Research and development expenses decreased by 39.20% year-over-year, totaling an absolute reduction of ¥9,571.14 million[10] - The cash outflow for purchasing goods and services was ¥844,889,768.27, up from ¥693,630,425.40 in the previous year, indicating an increase of about 21.83%[29] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 67,614, with no preferred shareholders restoring voting rights[16] - The largest shareholder, Beiyinmei Group Co., Ltd., holds 18.65% of shares, amounting to 201,418,500 shares, with 194,850,000 shares pledged[16] - The company has repurchased a total of 15,758,586 shares, accounting for 1.46% of the total share capital, which are held in a dedicated repurchase account[17] Strategic Initiatives - The company supports the establishment of an industrial incubation fund by its wholly-owned subsidiary to enhance the integration of industry and finance, with plans to acquire projects that align with its development strategy once they mature[18] - The company transferred 48% of its stake in Guangxi Quanan Sheng Enterprise Management Co., Ltd., which is no longer included in the consolidated financial statements[19] - The company will calculate financial assistance interest at an annualized rate of 5% based on the actual amount and duration of funds used by Guangxi Quanan Sheng[19] Other Information - The company has not disclosed any significant changes in user data or new product developments in this report[21] - The company did not report any net profit from subsidiaries prior to consolidation for the current and previous periods[27] - The company’s other comprehensive income for Q3 2022 was -¥538,118.52, a significant decline from ¥7,892,891.76 in the same period last year[27]

Financial Performance - The company's revenue for Q1 2022 was ¥696,112,450.13, representing a 22.80% increase compared to ¥566,858,555.71 in the same period last year[4] - Net profit attributable to shareholders was ¥20,126,374.67, up 38.45% from ¥14,537,381.04 year-on-year[4] - The net profit after deducting non-recurring gains and losses surged by 266.35% to ¥15,517,744.73 from ¥4,235,790.79 in the previous year[4] - Basic earnings per share doubled to ¥0.02 from ¥0.01 year-on-year[4] - The total operating revenue for the first quarter of 2022 was CNY 696,112,450.13, an increase of 22.8% compared to CNY 566,858,555.71 in the same period last year[23] - The net profit attributable to the parent company was CNY 20,126,374.67, compared to CNY 14,537,381.04, representing a year-on-year increase of 38.5%[24] Cash Flow and Liquidity - Operating cash flow increased by 145.02% to ¥52,895,828.43, compared to ¥21,588,202.87 in the same quarter last year[4] - Cash inflows from operating activities increased by 12.31% to ¥70,974,000.00, driven by higher sales revenue[11] - The net cash flow from operating activities was CNY 52,895,828.43, significantly higher than CNY 21,588,202.87 in the previous year[26] - The cash and cash equivalents at the end of the period totaled 606,082,937.03 CNY, a decrease from 640,302,877.54 CNY at the beginning of the period[27] - The net increase in cash and cash equivalents decreased by 140.69% to ¥-2000,250.00, primarily due to lower net cash from operating activities compared to investment and financing activities[12] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,112,136,081.48, a 1.05% increase from ¥4,069,421,166.85 at the end of the previous year[4] - The total current assets reached CNY 2,215,784,592.47, slightly up from CNY 2,183,321,715.52 at the start of the year[19] - The total liabilities increased to CNY 2,257,924,509.83 from CNY 2,232,686,402.91, indicating a rise of 1.1%[23] - The total equity attributable to shareholders of the parent company was CNY 1,802,455,204.51, compared to CNY 1,785,836,479.80, showing a growth of 0.9%[23] Operating Costs and Expenses - The company's operating costs rose by 43.50% to ¥38,487,000.00, reflecting the increase in revenue[9] - The total operating costs amounted to CNY 655,206,625.73, up from CNY 543,555,353.94, reflecting a growth of 20.5%[23] - The company incurred research and development expenses of CNY 4,553,454.36, slightly down from CNY 4,754,671.25[23] Investments and Financing Activities - The company established a joint venture, Yibei Intelligent (Hangzhou) Nutrition Technology Co., Ltd., with a registered capital of CNY 10 million, where the company holds a 40% stake[16] - The company repurchased 8,286,307 shares, accounting for 0.77% of the total share capital[15] - The company reported a total cash outflow from investment activities of 57,858,101.19 CNY in Q1 2022[27] - The cash outflow for debt repayment was 256,066,665.00 CNY, compared to 300,000,000.00 CNY in the previous year[27] Other Financial Metrics - The company reported a significant decrease in financial expenses by 73.56%, amounting to ¥426,000.00, due to reduced exchange losses[9] - The company reported a decrease in other comprehensive income, with a net amount of CNY -3,842,449.96 compared to CNY -1,396,328.67 in the previous year[24] - The company did not undergo an audit for the Q1 2022 report[28]

Financial Performance - The company's operating revenue for 2022 was ¥2,654,624,655.97, an increase of 4.53% compared to ¥2,539,560,089.66 in 2021[6]. - The net profit attributable to shareholders was -¥175,996,805.92, a decrease of 340.06% from ¥73,314,574.33 in the previous year[6]. - The cash flow from operating activities increased by 52.96% to ¥377,416,659.60 from ¥246,743,802.53 in 2021[6]. - The basic earnings per share for 2022 was -¥0.16, down 328.57% from ¥0.07 in 2021[6]. - Total assets at the end of 2022 were ¥3,877,108,863.41, a decrease of 4.73% from ¥4,069,421,166.85 at the end of 2021[6]. - The net assets attributable to shareholders decreased by 13.84% to ¥1,538,639,572.79 from ¥1,785,836,479.80 in 2021[6]. - The company reported a significant loss in the fourth quarter with a net profit attributable to shareholders of -¥220,246,516.27[31]. - The company is facing uncertainty regarding its ability to continue as a going concern, as indicated by negative net profits over the last three years[6]. Market and Product Development - The company is committed to expanding its market presence and sales scale despite industry challenges[5]. - The main product category, infant formula, generated a revenue of 2.276 billion CNY, with a year-on-year increase of 7.55%[42]. - The company is focusing on expanding its product matrix with innovative products like the "珍质系列" and "叶酸龙凤太" to meet evolving consumer demands[44]. - The company plans to launch three new product lines in 2023, focusing on organic and health-oriented products to meet market demand[111]. - The company has completed the registration of 10 key series and 30 products under the new national standards, with ongoing registration for other products[44]. - The infant formula market in China is expected to see significant growth, particularly in lower-tier cities, driven by increasing consumer trust in domestic products[44]. Cost Management and Operational Efficiency - The company plans to enhance cost management and expense control to improve competitiveness amid high operational costs[5]. - The operating cost for 2022 was 1.5034407 billion yuan, reflecting a year-on-year increase of 11.54%[55]. - The gross profit margin decreased to 43.37%, down 3.55 percentage points compared to the previous year, primarily due to increased sales discounts and rising raw material prices[55]. - The company aims to enhance operational efficiency by optimizing its industrial layout and reducing operational costs through standardized systems and information processes[105]. Corporate Governance and Compliance - The company is committed to improving corporate governance and transparency, ensuring compliance with all regulatory requirements[112]. - The company established an insider information reporting system to comply with regulations during the preparation of periodic reports[120]. - The company has strengthened its institutional framework to enhance decision-making processes for external investments, ensuring the protection of investors' rights[121]. - The independent auditor, Dahua Certified Public Accountants, issued an unqualified audit report with emphasis on certain matters for the fiscal year 2022, reflecting the company's financial status accurately[189]. Research and Development - The company is investing 200 million yuan in research and development for new technologies aimed at improving product quality and safety standards[111]. - The number of R&D personnel increased by 17.24% to 34, with a higher proportion of master's degree holders[75]. - The company focused on developing new infant formula products and innovative nutritional products to meet family health needs[74]. Social Responsibility and Community Engagement - The company donated over 2.6 million yuan to various charitable organizations during the reporting period[173]. - Beiyinmei's mission focuses on helping babies grow healthily, supporting mothers, and promoting family happiness[173]. - The company has been actively involved in social welfare projects, including the "Love Baby" and "Parenting" initiatives since 1993[173]. Employee Management and Compensation - The total number of employees at the end of the reporting period is 2,095, with 1,020 in the parent company and 1,075 in major subsidiaries[151]. - Employee compensation consists of basic salary, performance pay, and welfare allowances, with a strong link between performance results and income[152]. - The company has implemented stock option incentive plans to enhance employee satisfaction and loyalty[152]. Strategic Partnerships and Collaborations - The company is enhancing its collaboration with channel partners to explore strategic and capital cooperation opportunities[45]. - The company has established a joint venture with an investment of 15.51 million RMB, enhancing its operational capabilities[103]. - The company is actively exploring collaborations within the maternal and child ecosystem to strengthen its core business while expanding service offerings[104]. Financial Management and Investments - The company reported a total investment of ¥90,682,123.70 during the reporting period, a decrease of 12.28% compared to the previous year's investment of ¥103,381,626.03[87]. - The company has fully utilized the raised funds of ¥252,304,573.30 by the end of 2022, with a remaining balance of ¥649,985.00[93]. - The company has not reported any issues or problems regarding the use and disclosure of raised funds[97].

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20140919 号 | --- | --- | --- | --- | --- | |-------------------------|----------------------------|----------------------------------------------------------------|-------|-----------| | 投资者关系活动 | | █特定对象调研 □分析师会议 | | | | 类别 | □媒体采访 | □业绩说明会 | | | | | | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | | □其他 | （请文字说明其他活动内容） | | | | 参与单位名称及 | 安信证券 张龙 | | | | | 人员姓名 | 长信基金 刘亮 | | | | | | 国联安基金 | 林静 | | | | | 本次调研共有 3 | 位投资者参与 | | | | 时间 2014 | 年 9 月 19 日 | 10：00-11：30 | | ...

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20150901 号 | --- | --- | --- | |--------------|---------------------------|----------------------------------------------------------| | 投资者关系活 | □特定对象调研 □分析师会议 | | | 动类别 | □媒体采访 | □业绩说明会 | | | □新闻发布会 □路演活动 | | | | □现场参观 | | | | █其他 电话会议 | | | 参与单位名称 | 华泰证券及其客户 | | | 及人员姓名 | | | | 时间 2015 | 年 9 月 1 | 日 15：00-16 ： 00 | | | 地点 杭州市滨江区南环路 | 3758 号贝因美大厦 | | 上市公司接待 | 董事长:王振泰 | | | 人员姓名 | 董事会秘书 : 沈立军 | | | | 会议交流内容纪要： | | | 投资者关系活 | | 一、王振泰董事长发言：过去的一年里，奶粉行业出现了不少 | | ...

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20150910 号 | --- | --- | --- | --- | --- | --- | |-------------------------|--------------------|-----------------------------------------------------------|-------|--------------------------------------------------------|-------| | | | | | | | | 投资者关系活 | | █特定对象调研 □分析师会议 | | | | | 动类别 | □媒体采访 | □业绩说明会 | | | | | | | □新闻发布会 □路演活动 | | | | | | □现场参观 | | | | | | | □其他 | | | | | | 参与单位名称 | 中金公司 | | | | | | 及人员姓名 | 齐鲁证券 张喆 | | | | | | | 摩根士丹利 | | | | | | | 招商基金 杨熙 ...

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20150320 号 | --- | --- | --- | --- | |----------------|------------------------------|----------------------------------------------------|-------| | | | | | | 投资者关系活动 | | □特定对象调研 □分析师会议 | | | 类别 | □媒体采访 | □业绩说明会 | | | | □新闻发布会 □路演活动 | | | | | □现场参观 | | | | | █其他 | 战略合作投资者交流研讨会 | | | 参与单位名称及 | 兴业证券 | 黄茂 | | | 人员姓名 | 中投证券 蒋鑫 | | | | | 中信证券 钱向劲 | | | | | 中信证券 | 黄巍 | | | | 中信证券 陈梦瑶 | | | | | 平安证券 文献 | | | | | 长江证券 | 刘洁铭 | | | | 本次会议共有 7 | 位投资者参与 | | | 时间 2015 | ...

证券代码：002570 证券简称：贝因美 贝因美婴童食品股份有限公司 投资者关系活动记录表 编号：20150611 号 | --- | --- | --- | --- | --- | --- | --- | --- | --- | |--------------|----------------------|--------|----------------------------------------|-------|-------|-------|-------|-------| | 投资者关系活 | | | █特定对象调研 □分析师会议 | | | | | | | 动类别 | □媒体采访 | | □业绩说明会 | | | | | | | | | | □新闻发布会 □路演活动 | | | | | | | | □现场参观 | | | | | | | | | | □其他 | | （请文字说明其他活动内容） | | | | | | | 参与单位名称 | 中金公司 吕若晨 | | | | | | | | | 及人员姓名 | 国泰君安证券 闫伟 | | | | | | | | | | 华泰证券 贺琪 | | | ...